Detalhe da pesquisa
1.
Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
Diabetologia
; 67(7): 1245-1259, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38546821
2.
Impact of dietary carbohydrate, fat or protein restriction on the human gut microbiome: a systematic review.
Nutr Res Rev
; : 1-18, 2024 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38602133
3.
Correction to: Fasting in diabetes treatment (FIT) trial: study protocol for a randomised, controlled, assessor-blinded intervention trial on the effects of intermittent use of a fasting-mimicking diet in patients with type 2 diabetes.
BMC Endocr Disord
; 20(1): 164, 2020 Nov 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33143722
4.
Fasting in diabetes treatment (FIT) trial: study protocol for a randomised, controlled, assessor-blinded intervention trial on the effects of intermittent use of a fasting-mimicking diet in patients with type 2 diabetes.
BMC Endocr Disord
; 20(1): 94, 2020 Jun 24.
Artigo
Inglês
| MEDLINE | ID: mdl-32580710
5.
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1.
Blood
; 129(10): 1284-1295, 2017 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28053195
6.
Self-initiated lifestyle changes during a fasting-mimicking diet programme in patients with type 2 diabetes: a mixed-methods study.
BMC Prim Care
; 25(1): 148, 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38698355
7.
Metabolic impact of intermittent energy restriction and periodic fasting in patients with type 2 diabetes: a systematic review.
Nutr Rev
; 81(10): 1329-1350, 2023 09 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36888890
8.
A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer.
Oncotarget
; 7(44): 71536-71547, 2016 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27689397
9.
Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.
Oncotarget
; 7(47): 77021-77037, 2016 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-27776339